BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31397396)

  • 1. Advanced type 1 hyperoxaluria presenting as livedo racemosa in a patient with end-stage renal disease.
    Torres-Navarro I; Garcia-Bustos V; Botella-Estrada R; Rojas-Ferrer N; Moral-Moral P
    Indian J Dermatol Venereol Leprol; 2019; 85(5):493-495. PubMed ID: 31397396
    [No Abstract]   [Full Text] [Related]  

  • 2. Off-center fold: necrotizing livedo reticularis. Diagnosis: primary hyperoxaluria type I.
    O'Reilly MA; Meadows KP; Egan CA
    Arch Dermatol; 2001 Jul; 137(7):957-62. PubMed ID: 11453821
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary hyperoxaluria: report of a patient with livedo reticularis and digital infarcts.
    Marconi V; Mofid MZ; McCall C; Eckman I; Nousari HC
    J Am Acad Dermatol; 2002 Feb; 46(2 Suppl Case Reports):S16-8. PubMed ID: 11807460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal graft failure due to type 1 primary hyperoxaluria.
    Riksen NP; Timmers HJ; Assmann KJ; Huysmans FT
    Neth J Med; 2002 Nov; 60(10):407-10. PubMed ID: 12607592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute livedo racemosa in a patient with type 1 primary hyperoxaluria.
    Plörer A; Zelger B
    Arch Dermatol; 1996 Mar; 132(3):349. PubMed ID: 8607646
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adult type I primary hyperoxaluria: 2 cases confirmed by liver biopsy at end-stage renal insufficiency].
    Schillinger F; Mahmoud M; Montagnac R; Collin P; Milcent T
    Nephrologie; 1990; 11(4):217-21. PubMed ID: 2074921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary hyperoxaluria type 1-a rare hereditary metabolic disorder as cause of livedo racemosa].
    Linse KP; Enk A; Toberer F
    Dermatologie (Heidelb); 2024 Apr; 75(4):321-324. PubMed ID: 38167780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hyperoxaluria in a 27-year-old woman.
    Bogle MA; Teller CF; Tschen JA; Smith CA; Wang A
    J Am Acad Dermatol; 2003 Oct; 49(4):725-8. PubMed ID: 14512927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infantile primary hyperoxaluria type 1 with end stage renal failure.
    Khoo JJ; Pee S; Kamaludin DP
    Pathology; 2006 Aug; 38(4):371-4. PubMed ID: 16916735
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxalate kinetics and reversal of the complications after orthotopic liver transplantation in a patient with primary hyperoxalosis type 1 awaiting renal transplantation.
    Bastani B; Mistry BM; Nahass GT; Joh J; Dundoo G; Solomon H
    Am J Nephrol; 1999; 19(1):64-9. PubMed ID: 10085453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent cutaneous manifestations of hyperoxaluria after combined hepatorenal transplantation.
    Rubenstein MC; Martinelli PT; Bayer-Garner IB; Klebuc MJ; Curry JL; Hsu S
    Dermatol Online J; 2004 Jul; 10(1):10. PubMed ID: 15347492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical features of primary hyperoxaluria in end-stage renal disease.
    Absy MM
    Am J Nephrol; 1991; 11(4):301-4. PubMed ID: 1799188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusion of primary hyperoxaluria type I (PHI) in end-stage renal failure by enzymatic analysis of a percutaneous hepatic biopsy.
    Morgan SH; Danpure CJ; Bending MR; Eisinger AJ
    Nephron; 1990; 55(3):336-7. PubMed ID: 2370935
    [No Abstract]   [Full Text] [Related]  

  • 14. Massive bone marrow involvement in an end stage renal failure case with erythropoietin-resistant anemia and primary hyperoxaluria.
    Taşlı F; Özkök G; Ok ES; Soyer N; Mollamehmetoğlu H; Vardar E
    Ren Fail; 2013 Sep; 35(8):1167-9. PubMed ID: 23879652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disseminated ischemic necrosis and livedo racemosa in a chronic dialysis patient with calciphylaxis].
    Henschel A; Dannenberg L; Göbel U; Ott A; Schultz-Ehrenburg U
    Hautarzt; 1999 Jun; 50(6):439-44. PubMed ID: 10427515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary oxalosis and livedo reticularis. Apropos of a case].
    Bodemer C; Flament F; Grunfeld JP; De Prost Y
    Ann Dermatol Venereol; 1989; 116(10):721-4. PubMed ID: 2610464
    [No Abstract]   [Full Text] [Related]  

  • 17. A young patient with end-stage renal disease, dyspnoea, weakness, peripheral neuropathy and an unsuspected underlying disease.
    Wichmann G; Passauer J; Fischer R; Weise M; Gross P
    Nephrol Dial Transplant; 2003 Aug; 18(8):1670-2. PubMed ID: 12897114
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary hyperoxaluria: a rare but important cause of nephrolithiasis.
    Wong PN; Tong GM; Lo KY; Mak SK; Law EL; Wong AK
    Hong Kong Med J; 2002 Jun; 8(3):202-6. PubMed ID: 12055367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulcerating subcutaneous nodules and advanced renal failure: is it time for a new liver?
    Karakousis PC; Tomaszewski JE
    Nephrol Dial Transplant; 2001 Oct; 16(10):2095-6. PubMed ID: 11572906
    [No Abstract]   [Full Text] [Related]  

  • 20. Pruritic eruption in a patient with end-stage renal disease.
    Peng C; Mesiano D; Carr RA; Eke U; Shim TN
    Clin Exp Dermatol; 2021 Apr; 46(3):588-590. PubMed ID: 33259082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.